Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306745200 on September 24, 2003

J. Biol. Chem., Vol. 278, Issue 49, 48720-48726, December 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/49/48720    most recent
M306745200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allaman-Pillet, N.
Right arrow Articles by Bonny, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allaman-Pillet, N.
Right arrow Articles by Bonny, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calcium- and Proteasome-dependent Degradation of the JNK Scaffold Protein Islet-brain 1*

Nathalie Allaman-Pillet{ddagger}§, Joachim Størling¶, Anne Oberson{ddagger}, Raphael Roduit{ddagger}, Stéphanie Negri{ddagger}, Christelle Sauser{ddagger}, Pascal Nicod||, Jacques S. Beckmann{ddagger}, Daniel F. Schorderet{ddagger}, Thomas Mandrup-Poulsen¶**, and Christophe Bonny{ddagger}

From the {ddagger}Division of Medical Genetics and Unit of Molecular Genetics, ||Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland, Steno Diabetes Center, DK-2820 Gentofte, Denmark, and **Department of Molecular Medicine, Karolinska Institute, SE-171 77 Stockholm, Sweden

In models of type 1 diabetes, cytokines induce pancreatic {beta}-cell death by apoptosis. This process seems to be facilitated by a reduction in the amount of the islet-brain 1/JNK interacting protein 1 (IB1/JIP1), a JNK-scaffold with an anti-apoptotic effect. A point mutation S59N at the N terminus of the scaffold, which segregates in diabetic patients, has the functional consequence of sensitizing cells to apoptotic stimuli. Neither the mechanisms leading to IB1/JIP1 down-regulation by cytokines nor the mechanisms leading to the decreased capacity of the S59N mutation to protect cells from apoptosis are understood. Here, we show that IB1/JIP1 stability is modulated by intracellular calcium. The effect of calcium depends upon JNK activation, which primes the scaffold for ubiquitination-mediated degradation via the proteasome machinery. Furthermore, we observe that the S59N mutation decreases IB1/JIP1 stability by sensitizing IB1/JIP1 to calcium- and proteasome-dependent degradation. These data indicate that calcium influx initiated by cytokines mediates ubiquitination and degradation of IB1/JIP1 and may, therefore, provide a link between calcium influx and JNK-mediated apoptosis in pancreatic {beta}-cells.


Received for publication, June 25, 2003 , and in revised form, September 12, 2003.

* This work was supported by the Botnar Foundation, Danish Diabetes Association, Novo Nordisk A/S, Grant P-038/02 from the Gebert Rüf Stifstung Fundation, Juvenile Diabetes Research Foundation International Research Center Grant 4-2002-457, and Fonds National Suisse de la Recherche Scientifique Grant 3200-65139.01. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Unit of Molecular Genetics, Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland. Tel.: 41-21-314-3379; Fax: 41-21-314-3385; E-mail: Nathalie.Pillet{at}chuv.hospvd.ch.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Hartley, J. Brumell, and A. Volchuk
Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E1 - E10.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen
Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation
Endocr. Rev., May 1, 2008; 29(3): 334 - 350.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Ferdaoussi, S. Abdelli, J.-Y. Yang, M. Cornu, G. Niederhauser, D. Favre, C. Widmann, R. Regazzi, B. Thorens, G. Waeber, et al.
Exendin-4 Protects {beta}-Cells From Interleukin-1{beta}-Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
Diabetes, May 1, 2008; 57(5): 1205 - 1215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Zhou, J. S. Boomer, and T.-H. Tan
Protein Phosphatase 4 Is a Positive Regulator of Hematopoietic Progenitor Kinase 1
J. Biol. Chem., November 19, 2004; 279(47): 49551 - 49561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement